{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":23,"n_cols":5,"rows_kept":23,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[10,2,10,3],[11,2,11,3],[12,2,12,3],[16,2,16,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910643782903321"]
[null,null,"Titolo",null,"Ciba Foundation Symposium jointly with Committee for Symposia on Drug Action, on Adrenergic Mechanisms [[electronic resource] /] / editor for the British Pharmacological Society, J.R. Vane ; editors for the Ciba Foundation, G.E.W. Wolstenholme and Maeve O'Connor"]
[null,null,"Pubbl/distr/stampa",null,"Boston, : Little, Brown and Co., [1961? c1960]"]
[null,null,"ISBN",null,"1-280-76859-2"]
[{"$nulls":4},"9786613679369"]
[{"$nulls":4},"0-470-71920-6"]
[{"$nulls":4},"0-470-71671-1"]
[null,null,"Descrizione fisica",null,"1 online resource (666 p.)"]
[null,null,"Collana",null,"Ciba Foundation symposia"]
[null,null,"Disciplina",null,"612.45082"]
[null,null,"Soggetti",null,"Adrenergic mechanisms"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and indexes."]
[null,null,"Nota di contenuto",null,"ADRENERGIC MECHANISMS; CONTENTS; Opening address; Session 1 : Formafion and lnactivation of Adrenergic Transmitters; Formation of adrenergic transmitters; Formation of adrenaline and noradrenaline; Discussion; The fate of adrenaline and noradrenaline; 3-Methoxy-4-hydroxymandelic acid excretion in phaeochromocytoma; The metabolism of [α-l4CJ](±)-adrenaline in the cat; Discussion; Session 2: Storage of Catechol Aminer; Chairman's opening remarks; Origin, development and distribution of chromaffin cells; The storage of amines in the chromaffin cell"]
[{"$nulls":4},"Some observations on the synthesis and storage of catechol amines in the adrenaline-containing cells of the suprarenal medullaCell types of the adrenal medulla; Discussion; Session 3: The Adrenergic Neurone; Chairman's opening remarks; Release of sympathetic transmitter by nerve stimulation; Discussion; Interference with the release of transmitter in response to nerve stimulation; The effects of bretylium and allied agents on adrenergic neurones; The persistence of adrenergic nerve conduction after TM 10 or bretylium in the cat; Some pharmacological properties of guanethidine; Discussion"]
[{"$nulls":4},"Session 4: Adrenergic Mechanisms in ManEffects of adrenaline, noradrenaline and isopropylnoradrenaline in man; Effects of catechol amines on consecutive vascular sections; Discussion; Clinical effects of "]
[{"$nulls":4},"drugs which prevent the release of adrenergic transmitter; Bretylium; Discussion; Session 5 : Actions of Adrenaline and Noradrenaline on the Effector Cell; Chairman's opening remarks: The concept of receptors; Relationships between agonists, antagonists and receptor sites; Receptors for sympathomimetic amines; Sympathomimetic drugs and their receptors"]
[{"$nulls":4},"Various types of receptors for sympathomimetic drugsDiscussion; Biophysical changes produced by adrenaline and noradrenaline; Effect of adrenaline on depolarized smooth muscle; Discussion; The relation of adenosine-3',5'-phosphate to the action of catechol amines; The action of adrenaline on carbohydrate metabolism in relation to some of its pharmacodynamic efficts; Discussion; Session 6: Mechanism of Action of Other Sympathortiimetic Amines; Chairman's opening remarks; Tyramine and other amines as noradrenaline-releasing substances; Some observations on the effects of tyramine; Discussion"]
[{"$nulls":4},"The actions of sympathomimetic amines on tryptamine receptorsThe depolarizing and blocking action of amphetamine in the cat's superior cervical ganglion; Discussion; Session 7: Central Adrenergic Mechanisms; Chairman's opening remarks; Some central actions of adrenaline and noradrenaline when administered into the cerebral ventricles; Intervention of an adrenergic mechanism during brain stem reticular activation; Electrophysiological evidence relating to the rôle of adrenaline in the central nervous system; The passage of catechol amines through the blood-brain barrier"]
[{"$nulls":4},"Release of an adrenaline-like substance by electrical stimulation of the brain stem"]